• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护病房患者中耐碳青霉烯类肠杆菌科细菌的流行病学及死亡率分析:一项观察性研究

Epidemiology and Mortality Analysis Related to Carbapenem-Resistant Enterobacterales in Patients After Admission to Intensive Care Units: An Observational Study.

作者信息

Yoo Eun Hyung, Hong Hyo-Lim, Kim Eun Jin

机构信息

Department of Laboratory Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.

Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.

出版信息

Infect Drug Resist. 2023 Jan 7;16:189-200. doi: 10.2147/IDR.S391409. eCollection 2023.

DOI:10.2147/IDR.S391409
PMID:36644658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9833324/
Abstract

PURPOSE

The prevalence of carbapenem-resistant Enterobacterales (CRE) is rapidly increasing worldwide. Patients in the intensive care unit (ICU) are susceptible to CRE infections, and the related mortality rate is increased. It is necessary to understand CRE strains and risk factors for CRE infection in the ICU, to facilitate development of effective prophylactic strategies and treatments for ICU patients.

PATIENTS AND METHODS

This observational study was conducted in a tertiary hospital between 2016 and 2021. The subjects were patients with CRE cultured from specimens obtained after ICU admission. Genotypes of strains of CRE and carbapenemase-producing Enterobacterales (CPE) were identified, CRE infection was distinguished from mere colonization, and the clinical course of these patients was investigated.

RESULTS

Among 327 CRE cases, 84 (25.7%) showed infection and 243 (74.3%) showed colonization. Of these patients, 138 (42.2%) died. The CRE strains were (253 cases, 77.4%), (44 cases, 13.5%), and (15 cases, 4.6%). Among CRE cases, CPE was found in 249 (76.1%), including carbapenemase (KPC) in 164 (65.9%), and Guiana extended-spectrum (GES) in 64 (25.7%). A bedridden state, longer ICU stay, chronic kidney disease, malignancy, connective tissue disease, ICU admission for cardiac arrest, and CRE infection were associated with higher mortality, but cerebrovascular disease and ICU admission for trauma were associated with lower mortality. GES outbreak was caused by person-to-person transmission and was controlled through active surveillance.

CONCLUSION

The frequency of and KPC was the highest, but and GES was characteristically high in this study. Active CRE surveillance can be helpful for controlling outbreak.

摘要

目的

耐碳青霉烯类肠杆菌科细菌(CRE)在全球的流行率正在迅速上升。重症监护病房(ICU)的患者易感染CRE,且相关死亡率增加。有必要了解ICU中CRE菌株及CRE感染的危险因素,以促进制定针对ICU患者的有效预防策略和治疗方法。

患者与方法

本观察性研究于2016年至2021年在一家三级医院进行。研究对象为入住ICU后从标本中培养出CRE的患者。鉴定了CRE菌株和产碳青霉烯酶肠杆菌科细菌(CPE)的基因型,区分了CRE感染与单纯定植,并对这些患者的临床病程进行了调查。

结果

在327例CRE病例中,84例(25.7%)为感染,243例(74.3%)为定植。这些患者中,138例(42.2%)死亡。CRE菌株以[具体菌株1](253例,77.4%)、[具体菌株2](44例,13.5%)和[具体菌株3](15例,4.6%)为主。在CRE病例中,249例(76.1%)检测到CPE,其中164例(65.9%)为产KPC碳青霉烯酶,64例(25.7%)为产圭亚那扩展谱酶(GES)。卧床状态、ICU住院时间延长、慢性肾脏病、恶性肿瘤、结缔组织病、因心脏骤停入住ICU以及CRE感染与较高死亡率相关,但脑血管疾病和因创伤入住ICU与较低死亡率相关(此处原文中“but cerebrovascular disease and ICU admission for trauma were associated with lower mortality”前面的“but”使用不当,根据语境推测可能是“and”)。GES暴发是由人际传播引起的,并通过主动监测得到了控制。

结论

在本研究中,[具体菌株1]和KPC的出现频率最高,但[具体菌株2]和GES的出现频率也显著较高。积极的CRE监测有助于控制暴发。 (注:原文中部分菌株名称未给出具体中文翻译,保留了英文,需根据实际情况补充完整)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ca/9833324/37fd7856fe8e/IDR-16-189-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ca/9833324/cfcffb85dab7/IDR-16-189-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ca/9833324/c1d753bb0613/IDR-16-189-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ca/9833324/37fd7856fe8e/IDR-16-189-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ca/9833324/cfcffb85dab7/IDR-16-189-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ca/9833324/c1d753bb0613/IDR-16-189-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ca/9833324/37fd7856fe8e/IDR-16-189-g0003.jpg

相似文献

1
Epidemiology and Mortality Analysis Related to Carbapenem-Resistant Enterobacterales in Patients After Admission to Intensive Care Units: An Observational Study.重症监护病房患者中耐碳青霉烯类肠杆菌科细菌的流行病学及死亡率分析:一项观察性研究
Infect Drug Resist. 2023 Jan 7;16:189-200. doi: 10.2147/IDR.S391409. eCollection 2023.
2
Multicenter study on the prevalence of colonization due to carbapenem-resistant strains before and during the first year of COVID-19, Italy 2018-2020.2018-2020 年意大利 COVID-19 爆发前后碳青霉烯类耐药菌株定植流行的多中心研究。
Front Public Health. 2023 Dec 19;11:1270924. doi: 10.3389/fpubh.2023.1270924. eCollection 2023.
3
Prevalence and risk factors of carbapenem-resistant positivity by active screening in intensive care units in the Henan Province of China: A multi-center cross-sectional study.中国河南省重症监护病房主动筛查碳青霉烯类耐药菌阳性的患病率及危险因素:一项多中心横断面研究
Front Microbiol. 2022 Sep 14;13:894341. doi: 10.3389/fmicb.2022.894341. eCollection 2022.
4
Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.某大学医院 ICU 和 HSCT 病房高危患者中产碳青霉烯酶肠杆菌科直肠定植的流行病学和危险因素。
Antimicrob Resist Infect Control. 2020 Sep 23;9(1):155. doi: 10.1186/s13756-020-00816-4.
5
An observational study on carbapenem-resistant Enterobacterales (CRE) colonisation and subsequent risk of infection in an adult intensive care unit (ICU) at a tertiary care hospital in India.印度一家三级护理医院成人重症监护病房(ICU)中耐碳青霉烯类肠杆菌科细菌(CRE)定植及后续感染风险的观察性研究。
Infect Prev Pract. 2023 Sep 30;5(4):100312. doi: 10.1016/j.infpip.2023.100312. eCollection 2023 Dec.
6
A Longitudinal Nine-Year Study of the Molecular Epidemiology of Carbapenemase-Producing Isolated From a Regional Hospital in Taiwan: Predominance of Carbapenemase KPC-2 and OXA-48.台湾某地区医院产碳青霉烯酶分离株的分子流行病学九年纵向研究:碳青霉烯酶KPC-2和OXA-48占主导地位
Front Microbiol. 2022 Mar 11;13:703113. doi: 10.3389/fmicb.2022.703113. eCollection 2022.
7
Carbapenemase producing at a large teaching hospital in Ohio: comparison to state surveillance and retrospective analysis of patient characteristics.俄亥俄州一家大型教学医院产碳青霉烯酶情况:与州监测数据的比较及患者特征回顾性分析
Infect Prev Pract. 2024 Apr 27;6(2):100366. doi: 10.1016/j.infpip.2024.100366. eCollection 2024 Jun.
8
Molecular Epidemiology, Microbial Virulence, and Resistance of Carbapenem-Resistant Isolates in a Teaching Hospital in Guangzhou, China.中国广州一家教学医院中耐碳青霉烯类抗生素分离株的分子流行病学、微生物毒力和耐药性。
Microb Drug Resist. 2022 Jun;28(6):698-709. doi: 10.1089/mdr.2021.0156. Epub 2022 May 30.
9
Evaluation of HiCrome KPC Agar for the Screening of Carbapenem-Resistant Enterobacterales Colonization in the ICU Setting of a Tertiary Care Hospital.在一家三级护理医院的重症监护病房环境中,评估HiCrome KPC琼脂用于筛选耐碳青霉烯类肠杆菌科细菌定植的效果。
J Lab Physicians. 2021 Jul 12;13(4):358-361. doi: 10.1055/s-0041-1732494. eCollection 2021 Dec.
10
Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.采用小鼠大腿感染模型,对美罗培南、头孢吡肟或氨曲南与新型β-内酰胺酶抑制剂那库巴坦联合用药,针对耐碳青霉烯类和/或产碳青霉烯酶的肺炎克雷伯菌和大肠埃希菌进行药效学评价。
Int J Antimicrob Agents. 2021 May;57(5):106330. doi: 10.1016/j.ijantimicag.2021.106330. Epub 2021 Mar 28.

引用本文的文献

1
Global Epidemiology and Antimicrobial Resistance of Klebsiella Pneumoniae Carbapenemase (KPC)-Producing Gram-Negative Clinical Isolates: A Review.产肺炎克雷伯菌碳青霉烯酶(KPC)革兰阴性临床分离株的全球流行病学及抗菌药物耐药性:综述
Microorganisms. 2025 Jul 19;13(7):1697. doi: 10.3390/microorganisms13071697.
2
Antibiotic resistance profiles and risk factors of multidrug-resistant Escherichia coli in a large tertiary care hospital in a low- and middle-income country.低收入和中等收入国家一家大型三级医疗医院中多重耐药性大肠杆菌的抗生素耐药谱及危险因素
Sci Rep. 2025 Jul 22;15(1):26667. doi: 10.1038/s41598-025-12384-x.
3
Epidemiological data on the acquisition of carbapenem-resistant through weekly rectal swabs in non-critically ill patients undergoing antimicrobial therapy: a short-term surveillance study.

本文引用的文献

1
Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance.超广谱β-内酰胺酶和碳青霉烯酶的分子多样性与抗菌药物耐药性
J Intensive Care. 2020 Jan 28;8:13. doi: 10.1186/s40560-020-0429-6. eCollection 2020.
2
A Multispecies Cluster of GES-5 Carbapenemase-Producing Enterobacterales Linked by a Geographically Disseminated Plasmid.一种由具有地理分布性的质粒连接的产 GES-5 碳青霉烯酶肠杆菌科的多种族群。
Clin Infect Dis. 2020 Dec 17;71(10):2553-2560. doi: 10.1093/cid/ciz1130.
3
Plasmid evolution in carbapenemase-producing Enterobacteriaceae: a review.
通过对接受抗菌治疗的非重症患者每周进行直肠拭子采样获取耐碳青霉烯类情况的流行病学数据:一项短期监测研究。
Antimicrob Steward Healthc Epidemiol. 2025 May 13;5(1):e105. doi: 10.1017/ash.2025.169. eCollection 2025.
4
Risk factors, impact on outcomes, and molecular epidemiology of infections caused by carbapenem-resistant Enterobacterales in intensive care patients: a multicenter matched case-control study in Brazil.重症监护患者中耐碳青霉烯类肠杆菌科细菌感染的危险因素、对预后的影响及分子流行病学:巴西一项多中心配对病例对照研究
Crit Care Sci. 2025 Apr 14;37:e20250237. doi: 10.62675/2965-2774.20250237. eCollection 2025.
5
Antibiotic Resistance and Mortality in ICU Patients: A Retrospective Analysis of First Culture Growth Results.重症监护病房患者的抗生素耐药性与死亡率:首次培养生长结果的回顾性分析
Antibiotics (Basel). 2025 Mar 11;14(3):290. doi: 10.3390/antibiotics14030290.
6
Genome drafting of nosocomial infection CRE confirming resistance to colistin and eravacycline, carrying , , and , in neonatology from November to December 2023.2023年11月至12月新生儿科医院感染耐黏菌素和依拉环素的产碳青霉烯酶肠杆菌(CRE)的基因组草图绘制,携带[此处可能缺失具体基因信息]。
Front Cell Infect Microbiol. 2025 Jan 27;14:1528017. doi: 10.3389/fcimb.2024.1528017. eCollection 2024.
7
Carbapenem-resistant Enterobacterales infection and colonization in patients with severe burns: a retrospective cohort study in a single burn center.严重烧伤患者中耐碳青霉烯类肠杆菌科细菌感染与定植:一项在单一烧伤中心开展的回顾性队列研究
Antimicrob Resist Infect Control. 2025 Jan 29;14(1):3. doi: 10.1186/s13756-025-01514-9.
8
Emergence and expansion of carbapenem resistant enterobacterales in the Western Cape Province, South Africa.南非西开普省耐碳青霉烯肠杆菌科的出现和扩张。
PLoS One. 2024 Aug 26;19(8):e0309315. doi: 10.1371/journal.pone.0309315. eCollection 2024.
9
activity of novel apramycin-dextran nanoparticles and free apramycin against selected Dutch and Pakistani isolates.新型安普霉素-葡聚糖纳米颗粒和游离安普霉素对选定的荷兰和巴基斯坦分离株的活性。
Heliyon. 2023 Nov 25;9(12):e22821. doi: 10.1016/j.heliyon.2023.e22821. eCollection 2023 Dec.
10
Novel insights into genetic characteristics of -encoding plasmids from hospital sewage.对医院污水中编码质粒的遗传特征的新见解。
Front Microbiol. 2023 Aug 17;14:1209195. doi: 10.3389/fmicb.2023.1209195. eCollection 2023.
碳青霉烯酶产生肠杆菌科细菌中的质粒进化:综述。
Ann N Y Acad Sci. 2019 Dec;1457(1):61-91. doi: 10.1111/nyas.14223. Epub 2019 Aug 30.
4
Prevalence and Risk Factors of Carbapenem-resistant Acquisition in an Emergency Intensive Care Unit in a Tertiary Hospital in Korea: a Case-Control Study.韩国一家三级医院急诊重症监护病房耐碳青霉烯类获得性的流行状况和危险因素:一项病例对照研究。
J Korean Med Sci. 2019 May 13;34(18):e140. doi: 10.3346/jkms.2019.34.e140.
5
Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016).碳青霉烯类耐药肠杆菌科的表型和基因型特征:来自中国一项纵向大规模 CRE 研究的数据(2012-2016 年)。
Clin Infect Dis. 2018 Nov 13;67(suppl_2):S196-S205. doi: 10.1093/cid/ciy660.
6
Epidemiology and treatment of antimicrobialresistant gram-negative bacteria in Korea.韩国革兰氏阴性菌耐药性的流行病学与治疗
Korean J Intern Med. 2018 Mar;33(2):247-255. doi: 10.3904/kjim.2018.028. Epub 2018 Feb 27.
7
Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.耐碳青霉烯类肠杆菌科细菌感染的流行病学:来自中国 CRE 网络的报告。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01882-17. Print 2018 Feb.
8
Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.碳青霉烯类耐药肠杆菌科细菌定植(CRE)与重症患者随后的感染风险及90天死亡率:一项观察性研究
PLoS One. 2017 Oct 12;12(10):e0186195. doi: 10.1371/journal.pone.0186195. eCollection 2017.
9
Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.重症患者中耐碳青霉烯类肠杆菌科细菌的定植与感染:与非携带者的回顾性匹配队列比较
J Hosp Infect. 2016 Sep;94(1):54-9. doi: 10.1016/j.jhin.2016.05.018. Epub 2016 Jun 6.
10
Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic review.耐碳青霉烯类肠杆菌科细菌定植后的感染风险:一项系统评价
Am J Infect Control. 2016 May 1;44(5):539-43. doi: 10.1016/j.ajic.2015.12.005. Epub 2016 Feb 15.